FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978999675> ?p ?o ?g. }

• W1978999675 endingPage "473" @default.
• W1978999675 startingPage "464" @default.
• W1978999675 abstract "The pharmacokinetic parameters of amikacin and ceftazidime were assessed in four patients undergoing hemofiltration for septic shock. The parameters were assessed during hemofiltration and in the interim period. The concentration-time profiles of these two drugs in plasma, urine, and ultrafiltrate were investigated after intravenous perfusion (30 min). In all cases a 1-g dose of ceftazidime was administered; for amikacin, the dosage regimen was adjusted according to the patient's amikacin levels (250 to 750 mg). Concentrations of drug in all samples were assayed by high-performance liquid chromatography with UV detection for ceftazidime and by enzyme multiplied immunoassay for amikacin. The elimination half-life (t1/2) and the total clearance of amikacin ranged from 31.1 to 138.2 h and from 5.4 to 8.9 ml/min, respectively, during the interhemofiltration period in anuric patients. Hemofiltration substantially decreased the t1/2 (3.5 +/- 0.49 h) and increased the total clearance (89.5 +/- 11.8 ml/min). The hemofiltration clearance of amikacin represented 71% of the total clearance, and the hemofiltration process removed, on average, 60% of the dose. During hemofiltration, the elimination t1/2 of ceftazidime (2.8 +/- 0.69 h) was greatly reduced and the total clearance increased (74.2 +/- 11.2 ml/min) compared with those in the interhemofiltration period (9 to 43.7 h and 7.4 to 16.8 ml/min, respectively). About 55% of the administered dose was recovered in the filtrate, and the hemofiltration clearance of ceftazidime was 46 +/- 14.3 ml/min. A redistribution phenomenon (rebound) in the amikacin and ceftazidime concentrations in plasma (35 and 28%, respectively) was reported after hemofiltration in two patients. The MICs for 90% of the most important pathogens were exceeded by the concentrations of the two drugs in plasma during the whole treatment of these patients." @default.
• W1978999675 created "2016-06-24" @default.
• W1978999675 creator A5003665302 @default.
• W1978999675 creator A5014872500 @default.
• W1978999675 creator A5017244127 @default.
• W1978999675 creator A5026139306 @default.
• W1978999675 creator A5059035061 @default.
• W1978999675 creator A5079284539 @default.
• W1978999675 creator A5090070657 @default.
• W1978999675 creator A5091885566 @default.
• W1978999675 date "1993-03-01" @default.
• W1978999675 modified "2023-09-27" @default.
• W1978999675 title "Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration" @default.
• W1978999675 cites W1981341192 @default.
• W1978999675 cites W1982308783 @default.
• W1978999675 cites W1989230876 @default.
• W1978999675 cites W1990423362 @default.
• W1978999675 cites W1992160561 @default.
• W1978999675 cites W1994457186 @default.
• W1978999675 cites W2008056852 @default.
• W1978999675 cites W2015020338 @default.
• W1978999675 cites W2017955848 @default.
• W1978999675 cites W2039986417 @default.
• W1978999675 cites W2061627955 @default.
• W1978999675 cites W2078251568 @default.
• W1978999675 cites W2141102394 @default.
• W1978999675 cites W2159013499 @default.
• W1978999675 cites W2170487356 @default.
• W1978999675 cites W2254173580 @default.
• W1978999675 cites W2276290750 @default.
• W1978999675 cites W2334343593 @default.
• W1978999675 cites W2416081518 @default.
• W1978999675 cites W2433974225 @default.
• W1978999675 cites W2472356128 @default.
• W1978999675 cites W2496817583 @default.
• W1978999675 cites W2833736 @default.
• W1978999675 cites W2183448015 @default.
• W1978999675 doi "https://doi.org/10.1128/aac.37.3.464" @default.
• W1978999675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/187694" @default.
• W1978999675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8460915" @default.
• W1978999675 hasPublicationYear "1993" @default.
• W1978999675 type Work @default.
• W1978999675 sameAs 1978999675 @default.
• W1978999675 citedByCount "28" @default.
• W1978999675 countsByYear W19789996752012 @default.
• W1978999675 countsByYear W19789996752016 @default.
• W1978999675 countsByYear W19789996752017 @default.
• W1978999675 countsByYear W19789996752018 @default.
• W1978999675 countsByYear W19789996752019 @default.
• W1978999675 countsByYear W19789996752021 @default.
• W1978999675 countsByYear W19789996752022 @default.
• W1978999675 crossrefType "journal-article" @default.
• W1978999675 hasAuthorship W1978999675A5003665302 @default.
• W1978999675 hasAuthorship W1978999675A5014872500 @default.
• W1978999675 hasAuthorship W1978999675A5017244127 @default.
• W1978999675 hasAuthorship W1978999675A5026139306 @default.
• W1978999675 hasAuthorship W1978999675A5059035061 @default.
• W1978999675 hasAuthorship W1978999675A5079284539 @default.
• W1978999675 hasAuthorship W1978999675A5090070657 @default.
• W1978999675 hasAuthorship W1978999675A5091885566 @default.
• W1978999675 hasBestOaLocation W19789996751 @default.
• W1978999675 hasConcept C112705442 @default.
• W1978999675 hasConcept C126322002 @default.
• W1978999675 hasConcept C141071460 @default.
• W1978999675 hasConcept C146957229 @default.
• W1978999675 hasConcept C185592680 @default.
• W1978999675 hasConcept C2776968632 @default.
• W1978999675 hasConcept C2777427914 @default.
• W1978999675 hasConcept C2777628635 @default.
• W1978999675 hasConcept C2777637488 @default.
• W1978999675 hasConcept C2778063415 @default.
• W1978999675 hasConcept C2778384902 @default.
• W1978999675 hasConcept C2778865887 @default.
• W1978999675 hasConcept C42219234 @default.
• W1978999675 hasConcept C501593827 @default.
• W1978999675 hasConcept C523546767 @default.
• W1978999675 hasConcept C54355233 @default.
• W1978999675 hasConcept C55493867 @default.
• W1978999675 hasConcept C71924100 @default.
• W1978999675 hasConcept C86803240 @default.
• W1978999675 hasConcept C98274493 @default.
• W1978999675 hasConceptScore W1978999675C112705442 @default.
• W1978999675 hasConceptScore W1978999675C126322002 @default.
• W1978999675 hasConceptScore W1978999675C141071460 @default.
• W1978999675 hasConceptScore W1978999675C146957229 @default.
• W1978999675 hasConceptScore W1978999675C185592680 @default.
• W1978999675 hasConceptScore W1978999675C2776968632 @default.
• W1978999675 hasConceptScore W1978999675C2777427914 @default.
• W1978999675 hasConceptScore W1978999675C2777628635 @default.
• W1978999675 hasConceptScore W1978999675C2777637488 @default.
• W1978999675 hasConceptScore W1978999675C2778063415 @default.
• W1978999675 hasConceptScore W1978999675C2778384902 @default.
• W1978999675 hasConceptScore W1978999675C2778865887 @default.
• W1978999675 hasConceptScore W1978999675C42219234 @default.
• W1978999675 hasConceptScore W1978999675C501593827 @default.
• W1978999675 hasConceptScore W1978999675C523546767 @default.
• W1978999675 hasConceptScore W1978999675C54355233 @default.
• W1978999675 hasConceptScore W1978999675C55493867 @default.

• next